Synthesis and bioactivity of a Goralatide analog with antileukemic activity
- Zhiliang Li,
- Iryna Oleksandrivna Lebedyeva,
- Vita M. Golubovskaya,
- William G. Cance,
- Khalid A. Alamry,
- Hassan M. Faidallah
- University of Florida,
- Roswell Park Cancer Institute,
- King Abdulaziz University
Scholary Output:
Contribution to journal
Article
Peer-reviewAbstract
Natural tetrapeptide Goralatide (AcSDKP) is a selective inhibitor of primitive haematopoietic cell proliferation. It is not stable in vivo and decomposes within 4.5 min when applied to live cells. In this work we developed an analog of Goralatide that exhibits cytotoxicity towards human myeloid HL-60, HEL, Nalm-6 leukemia cells, endothelial HUVEC, glioblastoma U251 and transformed kidney 293T cells. The Goralatide analog showed significant stability in organic solution with no tendency to degrade oxidatively.
Publication Information
Output type
Scholary Output:
Contribution to journal
Article
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages 5056-5060 (5 pages)Journal (Volume, Issue Number)
Bioorganic and Medicinal Chemistry (Volume 23, Issue 15)Publication milestones
- Published - 07/23/2015
Publication status
Published - 07/23/2015
ISSN
0968-0896Publication IDs
- Scopus: 84937519253
- PubMed: 26048023
Publication metrics
Metrics
SciVal
Author count
8
SciVal
Paper percentile
23
Fractional count
1
Fractional count
0.13
Fractional count
7
Fractional count
0.88
Fractional count
1
Fractional count
1
PlumX, opens in new tab
Citation count
2
Captures
10
Funding Details
We thank the University of Florida for the support of this project. This project was also supported by the NSTIP Strategic Technologies Program in the Kingdom of Saudi Arabia-Project N o . 12-ADV2732-03. The authors also, acknowledge with thanks Science and Technology Unit, King Abdulaziz University for technical support. The authors are grateful to Dr. Rachel A. Jones, Mr. Z. Wang for helpful discussions and Dr. M.C.A. Dancel for HRMS analyses.
FundersFunding numbers
NSTIP Strategic Technologies Program
-UF
-